Richard Blackburn, Azurity Pharmaceuticals CEO

Azu­ri­ty Phar­ma­ceu­ti­cals con­tin­ues its win streak as it bags an­oth­er ap­proval from the FDA

Mass­a­chu­setts-based Azu­ri­ty Phar­ma­ceu­ti­cals has been do­ing well this year in get­ting its prod­ucts past FDA ap­proval, and the com­pa­ny is look­ing to con­tin­ue that trend …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.